These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28638573)

  • 21. The diagnosis of acute intermittent porphyria combined with seizures: Case report.
    Wang Z; Cheng L; Liang X; Jiang H; Shen R
    Medicine (Baltimore); 2023 Dec; 102(50):e36167. PubMed ID: 38115298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Challenges of Acute Porphyria in the Young Adult.
    Burns S; Harmel A; Miller S; Pucci GF; Greco J; Pulley M; Pizzi M
    Neurohospitalist; 2022 Apr; 12(2):377-382. PubMed ID: 35419127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Intermittent Porphyria Presenting with Posterior Reversible Encephalopathy Syndrome: A Rare Cause of Abdominal Pain and Seizures.
    Sarala Kumari D; Arumilli MN; Siva Kumar Reddy L; Reddy DN; Motor R
    Indian J Crit Care Med; 2020 Aug; 24(8):724-726. PubMed ID: 33024385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel mutation c.457C > T p.Q153 in the HMBS gene in a Mexican woman with acute intermittent porphyria.
    Malagon-Rangel J; Solis JG; Zavala-Jonguitud LF; Basile-Alvarez MR; Malagon-Liceaga A
    Clin Case Rep; 2023 Nov; 11(11):e8100. PubMed ID: 37900716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unveiling the Chameleon: A Case Report on Acute Intermittent Porphyria.
    Shrestha M; Amin S; Reggio C; Pokhrel A; Munankami S; Nypaver J; Gupta R; Donato A
    Cureus; 2024 Mar; 16(3):e56222. PubMed ID: 38618379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor.
    Barreda-Sánchez M; Buendía-Martínez J; Glover-López G; Carazo-Díaz C; Ballesta-Martínez MJ; López-González V; Sánchez-Soler MJ; Rodriguez-Peña L; Serrano-Antón AT; Gil-Ferrer R; Martínez-Romero MDC; Carbonell-Meseguer P; Guillén-Navarro E
    Orphanet J Rare Dis; 2019 Feb; 14(1):59. PubMed ID: 30808393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion.
    Floderus Y; Sardh E; Möller C; Andersson C; Rejkjaer L; Andersson DE; Harper P
    Clin Chem; 2006 Apr; 52(4):701-7. PubMed ID: 16497943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocyte transplantation ameliorates the metabolic abnormality in a mouse model of acute intermittent porphyria.
    Yin Z; Wahlin S; Ellis EC; Harper P; Ericzon BG; Nowak G
    Cell Transplant; 2014; 23(9):1153-62. PubMed ID: 23582197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria.
    Aarsand AK; Petersen PH; Sandberg S
    Clin Chem; 2006 Apr; 52(4):650-6. PubMed ID: 16595824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.
    Sassa S; Solish G; Levere RD; Kappas A
    J Exp Med; 1975 Sep; 142(3):722-31. PubMed ID: 1165472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive care management of patients with acute intermittent porphyria: Clinical report of four cases and review of literature.
    Mehta M; Rath GP; Padhy UP; Marda M; Mahajan C; Dash HH
    Indian J Crit Care Med; 2010 Apr; 14(2):88-91. PubMed ID: 20859493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute intermittent porphyria: psychosis as the only clinical manifestation.
    Ellencweig N; Schoenfeld N; Zemishlany Z
    Isr J Psychiatry Relat Sci; 2006; 43(1):52-6. PubMed ID: 16910386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyria.
    Johansson A; Nowak G; Möller C; Blomberg P; Harper P
    Mol Ther; 2004 Aug; 10(2):337-43. PubMed ID: 15294180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular diagnostics of acute intermittent porphyria.
    Kauppinen R
    Expert Rev Mol Diagn; 2004 Mar; 4(2):243-9. PubMed ID: 14995910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients.
    Lissing M; Wester A; Vassiliou D; Floderus Y; Harper P; Sardh E; Wahlin S
    J Inherit Metab Dis; 2023 Nov; 46(6):1186-1194. PubMed ID: 37650859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.
    Marsden JT; Rees DC
    J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations.
    Loskove Y; Yasuda M; Chen B; Nazarenko I; Cody N; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):352-357. PubMed ID: 30385147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute intermittent porphyria: mutation analysis and identification of gene carriers in a German kindred by PCR-DGGE analysis.
    Petrides PE
    Skin Pharmacol Appl Skin Physiol; 1998; 11(6):374-80. PubMed ID: 10343207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria.
    Anderson KE; Alvares AP; Sassa S; Kappas A
    Clin Pharmacol Ther; 1976 Jan; 19(1):47-54. PubMed ID: 1245093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational disease model of phenobarbital-induced acute attacks in an acute intermittent porphyria mouse model.
    Vera-Yunca D; Serrano-Mendioroz I; Sampedro A; Jericó D; Trocóniz IF; Fontanellas A; Parra-Guillén ZP
    Mol Genet Metab; 2019 Nov; 128(3):367-375. PubMed ID: 30639045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.